Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 percent of children who received omalizumab and OIT could safely consume two-gram portions of at least two foods to which they were allergic, compared with only a third of children who received placebo and OIT.
More than 10 years ago, U.S. tobacco companies were ordered to run ads about the bad effects of tobacco products. On Nov. 26, 2017, the court-ordered ads began. Tobacco smoke can cause a lot of damage to your health, even if you aren’t the one smoking. In 2006, a court found several major tobacco companies guilty of misleading the public about the dangers of tobacco products. The companies are finally running ads in major newspapers and on TV stations. These ads have to include specific...
Asthma research methods have been changing during the past several years. Research is more effective when researchers and patients work together to better understand asthma and find new treatments. At the Asthma and Allergy Foundation of America (AAFA), we feel your voice is valuable in asthma research. We support efforts to help you be an active part of the future of asthma management and treatments.
Some people are hesitant to participate in research. This may be because of fear of the unknown or from past stories. But today, patients have rights to protect them during research studies. Before you join a study, you will asked to sign an informed consent document.
We need asthma research so experts can find and create new treatments for asthma, and hopefully a cure. Experts decide what research is needed by looking at the effects of asthma.
More than 8 percent of children in the U.S. currently have asthma. Did you know early exposure to some allergens may reduce a child’s asthma risk?
When you have asthma, you may have different health care providers who help you manage your asthma. These may include a primary care doctor, specialists and other experts who oversee parts of your treatment plan. Since proper asthma management is key, you need to understand each one’s focus and the role they play in your care. This is the first step toward building a partnership with your health care team for the best quality of life possible.
When you hear about medical research, you probably hear about an organization called the NIH. The NIH is the United States’ medical research agency. It is also one of the top medical research agencies in the world.
The Asthma and Allergy Foundation of America (AAFA) believes your voice is valuable part of asthma research. And we want to empower people with asthma, caregivers and health care providers to take an active role in research. Promoting Asthma Patient Engagement in Research (PAPER) is a new research project from AAFA and the Patient-Centered Outcomes Research Institute (PCORI). Through this project, you can influence research that improves asthma understanding and treatment.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Phase 3 investigational study evaluating dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and key secondary endpoints.
New research shows that climate change is already a significant public health issue and a looming global health emergency. Its findings, outlined in The Lancet medical journal, demonstrate the various ways climate change is already affecting the health of people across the planet, today.
The Asthma and Allergy Foundation of America is sharing this press release from the 2017 ACAAI Scientific Annual Meeting to bring you the latest research news quickly. [PRESS RELEASE] Eczema Plus Family History Can Mean a Longer Hospital Stay for Kids with Asthma Study finds number of allergies don’t necessarily affect length of hospital stay. BOSTON, MA (October 27, 2017) – Asthma and allergies are related, and many people who suffer from asthma have allergies that trigger their asthma.
If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults. Although many adults with atopic dermatitis (commonly known as eczema) develop the disease in childhood and carry it through life, a large number are first diagnosed in adulthood – a trend being discussed at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting.
Two studies being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting show there may be even more reason to love your dog.